Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial
Titel:
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial
Auteur:
Harrison, Claire N Vannucchi, Alessandro M Platzbecker, Uwe Cervantes, Francisco Gupta, Vikas Lavie, David Passamonti, Francesco Winton, Elliott F Dong, Hua Kawashima, Jun Maltzman, Julia D Kiladjian, Jean-Jacques Verstovsek, Srdan